The COVID-19 Pandemic – News and Features

A prototype at-home test for SARS-CoV-2 that requires a non-invasive saliva sample has been shown to be comparable to RT-PCR in terms of specificity and sensitivity.

A transposable element or "jumping" gene in mice has been shown to control the immune system in response to viral infection, promoting host survival.

An ongoing program that monitors wastewater for the presence of SARS-CoV-2 and has effectively predicted subsequent surges in COVID-19 cases in San Diego has been expanded to detect the presence of monkeypox.

The tuberculosis (TB) vaccine, bacille Calmette-Guérin (BCG), is one of the most widely administered vaccines across the globe. Nearly 100 years old, it is the only vaccine ever administered to treat TB, which afflicts more than 10 million people each year.

In this interview with Bryan Kobel, CEO of TC Biopharm, we find out about gamma-delta T-cell therapy, including how it works, its applications and how TC Biopharm developed its pioneering gamma-delta treatment for acute myeloid leukemia.

In 2020, more than 1.5 million people died of tuberculosis (TB). Now, researchers have developed a TB drug that showed potential with just one injection that lasts at least four months, improving on current treatment which requires daily medication.

According to a study, all home delivery options for grocery shopping produced lower emissions than driving an internal-combustion-engine pickup truck to a store for in-store shopping.

Scientists at the University of California, Berkeley, have created a new COVID-19 therapeutic that could one day make treating SARS-CoV-2 infections as easy as using a nasal spray for allergies.

According to a study, almost 90% of people living with opioid use disorder are not receiving medications proven to reduce opioid overdoses by more than 50%.

Researchers have produced a method to turn carbenes, short-lived, high-energy molecules, into much more stable ones for the synthesis of new drugs.